|
MG-115
|
MG115,蛋白酶體抑制劑
|
133407-86-0
|
|
Afatinib-d
|
阿法替尼D6
|
1313874-96-2
|
|
PF-4693627
|
PF-4693627
|
1312815-93-2
|
|
CU-CPT 4a
|
化合物CU CPT 4A
|
1279713-77-7
|
|
MRT-81
|
化合物MRT-81
|
1263132-08-6
|
|
SKI-178
|
化合物SKI-178
|
1259484-97-3
|
|
2-TEDC
|
(E)-2-(噻吩-2-基)乙基 2-氰基-3-(3,4-二羥基苯基)丙烯酸酯
|
132465-10-2
|
|
C,
|
NUC-3373
|
1332837-31-6
|
|
PERK-IN-2
|
PERK-IN-2
|
1337531-83-5
|
|
Fluzoparib
|
氟唑帕利
|
1358715-18-0
|
|
M435-1279
|
化合物 M435-1279
|
1359431-16-5
|
|
Plitidepsin
|
普拉泰
|
137219-37-5
|
|
5,7-Dichlorokynurenic acid
|
5,7-二氯犬尿喹啉酸
|
131123-76-7
|
|
Saclofen
|
3-氨基-2-(4-氯苯基-丙烷磺酸
|
125464-42-8
|
|
CYP3cide
|
PF-4981517
|
1390637-82-7
|
|
Apixaban-
|
阿哌沙班雜質(zhì)13C-D3
|
1261393-15-0
|
|
GNF179
|
GNF179
|
1261114-01-5
|
|
Carbamazepine-d
|
1332295-35-8
|
1332295-35-8
|
|
(1E)-CFI-400437 dihydrochloride
|
CS-2656
|
1247000-76-5
|
|
NMS-P515
|
NMS-P515
|
1262395-13-0
|
|
Lansoprazole sulfone
|
蘭索拉唑磺酸鹽
|
131926-99-3
|
|
Amsilarotene
|
4-[[3,5-二(三甲基硅烷基)苯甲?；鵠氨基]苯甲酸
|
125973-56-0
|
|
DMU-212
|
3,4,5,4'-四甲氧基二苯乙烯
|
134029-62-2
|
|
Febuxostat-d
|
非布索坦 -D9
|
1246819-50-0
|
|
Isavuconazole-d
|
愛莎康唑-D4
|
1346598-58-0
|
|
A-887826
|
5-(4-丁氧基-3-氯苯基)-N-[[2-(4-嗎啉)-3-吡啶基]甲基]-3-吡啶甲酰胺
|
1266212-81-0
|
|
JGB1741
|
JGB1741
|
1256375-38-8
|
|
ML289
|
[(3R)-3-(Hydroxymethyl)-1-piperidinyl][4-[2-(4-methoxyphenyl)ethynyl]phenyl]-methanone
|
1382481-79-9
|
|
RKI-1313
|
1-(3-METHOXYBENZYL)-3-(4-(PYRIDIN-4-YL)THIAZOL-2-YL)UREA
|
1342276-76-9
|
|
Sofosbuvir impurity F
|
索菲布韋雜質(zhì)
|
1337482-17-3
|
|
Niranthin
|
N-芐基-N-甲基-1-(4-(三氟甲基)芐基)哌啶-3-甲酰胺
|
1350920-22-7
|
|
FXa-IN-1
|
XA因子的特異性顯色底物多肽
|
1379822-04-4
|
|
DODAP
|
DODAP
|
127512-29-2
|
|
OD1
|
[2H5]-普羅帕酮鹽酸鹽
|
1346605-05-7
|
|
CAIX Inhibitor S4
|
CAIX Inhibitor S4
|
1330061-67-0
|
|
Quilseconazole
|
Quilseconazole
|
1340593-70-5
|
|
CDC25B-IN-2
|
化合物BIA
|
134271-74-2
|
|
BI 99179
|
BI-99179
|
1291779-76-4
|
|
Alphitolic acid
|
尼羅替尼-D6
|
1268356-17-7
|
|
Izilendustat
|
1303512-02-8
|
1303512-02-8
|
|
(Rac)-Apremilast-d
|
阿普斯特D5 (RACEMIC)
|
1258597-61-3
|
|
DPQ
|
DMEM低糖
|
129075-73-6
|
|
Aminoglutethimide
|
氨魯米特
|
125-84-8
|
|
5α-Hydroxycostic acid
|
5Α-HYDROXYCOSTIC ACID
|
132185-83-2
|
|
URB937
|
URB937
|
1357160-72-5
|
|
Apremilast-d
|
阿普斯特-D5
|
1258597-47-5
|
|
IPI-9119
|
IPI-9119
|
1346564-56-4
|
|
TASP0415914
|
CS-2671
|
1292300-75-4
|
|
AUNP-12
|
AURIGENE-012;AUR 012
|
1353563-85-5
|
|
Umibecestat
|
Umibecestat
|
1387560-01-1
|
|
ML198
|
化合物ML198
|
1380716-06-2
|
|
TK05
|
TK05
|
1245734-61-5
|
|
Cassiaside
|
4H-Naphtho[2,3-b]pyran-4-one, 6-(β-D-glucopyranosyloxy)-5,8-dihydroxy-2-methyl-
|
13709-03-0
|
|
Ivabradine metabolite N-Demethyl Ivabradine hydrochloride
|
N-去甲鹽酸伊伐布雷定
|
1246638-08-3
|
|
UNC1062
|
UNC 1025
|
1350549-36-8
|
|
TAI-1
|
TAI-1
|
1334921-03-7
|
|
LDHA-IN-4
|
AZ-33
|
1370290-34-8
|
|
Icosabutate
|
1253909-57-7
|
1253909-57-7
|
|
PF-05241328
|
1-[5-CHLORO-6-(2-METHYLPROPOXY)PYRIDIN-3-YL]-3-METHYL-N-METHYLSULFONYLINDAZOLE-5-CARBOXAMIDE
|
1387633-03-5
|
|
BACE1-IN-1
|
1310347-50-2
|
1310347-50-2
|
|
Vodobatinib
|
K0706
|
1388803-90-4
|
|
1-Hydroxyanthraquinone
|
1-羥基蒽醌
|
129-43-1
|
|
UNC569
|
CS-2399
|
1350547-65-7
|
|
SR9186
|
N-(4'-Cyano[1,1'-biphenyl]-4-yl)-N'-[4-(3H-iMidazo[4,5-b]pyridin-7-yl)phenyl] Urea
|
1361414-26-7
|
|
Evolocumab
|
依洛尤單抗
|
1256937-27-5
|
|
SR1664
|
4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid
|
1338259-05-4
|
|
MMV390048
|
化合物MMV390048
|
1314883-11-8
|
|
BAY1082439
|
N-[8-[[(2R)-2-羥基-3-(嗎啉-4-基)丙基]氧基]-7-甲氧基-2,3-二氫咪唑并[1,2-C]喹唑啉-5-基]-2-甲基吡啶-3-甲酰胺
|
1375469-38-7
|
|
Trilaciclib
|
曲拉西利
|
1374743-00-6
|
|
MOMIPP
|
艾司西酞普蘭雜質(zhì)
|
1363421-46-8
|
|
EML4-ALK kinase inhibitor 1
|
EML4-ALK kinase inhibitor 1
|
1373409-08-5
|
|
IL-4-inhibitor-1
|
IL-4 INHIBITOR
|
1332184-63-0
|
|
Aureobasidin A
|
巴西芬凈
|
127785-64-2
|
|
(rac)-(trans)-Paroxetine-d
|
決奈達(dá)隆-d6鹽酸鹽
|
1329809-23-5
|
|
YM-750
|
化合物YM 750
|
138046-43-2
|
|
Eberconazole nitrate
|
硝酸依柏康唑
|
130104-32-4
|
|
PF9601N
|
PF 9601N
|
133845-63-3
|
|
ON1231320
|
CS-2589
|
1312471-39-8
|
|
Samatasvir
|
ATOLIHZIXHZSBA-BTSKBWHGSA-N
|
1312547-19-5
|
|
Gallic aldehyde
|
3,4,5-三羥基苯甲醛
|
13677-79-7
|
|
proTAME
|
proTAME
|
1362911-19-0
|
|
Ibezapolstat
|
ACX-362E
|
1275582-97-2
|
|
Acetic acid potassium 99%
|
乙酸鉀
|
127-08-2
|
|
ONO-8430506
|
化合物ONO-8430506
|
1354805-08-5
|
|
Pagoclone
|
帕戈隆
|
133737-32-3
|
|
SCD1 inhibitor-3
|
化合物SCD1 INHIBITOR-3
|
1282606-48-7
|
|
Icenticaftor
|
3-氨基-6-甲氧基-N-[(2S)-3,3,3-三氟-2-羥基-2-甲基丙基]-5-(三氟甲基)-2-吡啶甲酰胺
|
1334546-77-8
|
|
Lutein
|
葉黃素
|
127-40-2
|
|
JTE-952
|
JTE 952)
|
1255303-54-8
|
|
Chiauranib
|
1-Naphthalenecarboxamide, N-(2-aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]-
|
1256349-48-0
|
|
YH-306
|
化合物 T24642
|
1373764-75-0
|
|
KL-11743
|
KL11743
|
1369452-53-8
|
|
FIDAS-3
|
FIDAS-3
|
1266684-01-8
|
|
FEMA 4809
|
化合物 T27308
|
1374760-95-8
|
|
Tolnaftate-d
|
FUSNMLFNXJSCDI-BTSZWIDXSA-N
|
1329835-64-4
|
|
cis-2-Dodecenoic acid
|
米索硝唑
|
13551-87-6
|
|
Modoflaner
|
化合物MODOFLANER
|
1331922-53-2
|
|
TJ-M2010-5
|
化合物TJ-M2010-5
|
1357471-57-8
|
|
SCD1 inhibitor-4
|
1H-Imidazole-4-carboxamide, 5-methyl-N-(1-methyl-1H-pyrazol-3-yl)-1-[[3-(trifluoromethyl)phenyl]methyl]-
|
1295541-87-5
|
|
Fosciclopirox
|
Fosciclopirox
|
1380539-06-9
|